Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

Mansoura University

Status: Completed

Conditions: Behçet's Diseasecases

Treatments: Diagnostic Test: Serum calprotectin and IMA concentrations

Study type: Observational

Funder types: Other

Identifiers

NCT05868538

R.22.10.1905 - 2022/10/17

Details and patient eligibility

About

Behçet's Disease activity was evaluated using BD Current Activity Form (BDCAF). Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.

Enrollment: 60 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• new case of Behçet's disease available medical record Well known duration of BD, Well known current treatment used Well known current organ involvement

Exclusion criteria

• concomitant autoimmune or auto-inflammatory disorder; acute or chronic infections; cancer; diabetes; heart failure; gestation or up to six months after birth

Trial design

60 participants in 2 patient groups

Patients

Treatment:

Diagnostic Test: Serum calprotectin and IMA concentrations

control

Treatment:

Diagnostic Test: Serum calprotectin and IMA concentrations